Hata Yujiro S
- SEC CIK
- 0001649119
No open-market purchases or sales filed in the past year.
Current role at each company
- ENTA Enanta Pharmaceuticals IncDirectoras of Mar 13, 2026
- IDYA IDEAYA Biosciences, Inc.President and CEOas of Feb 2, 2026
- XNCR Xencor IncDirectoras of Jun 27, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Hata Yujiro S as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
IDYA IDEAYA Biosciences, Inc.
President and CEO5 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 16, 2024 (view filing) | May 14-16 | 2 days | Hata Yujiro SPresident and CEO | SSale | −175.0K | $42.27 | −$7.40M | −20.5%677.9K after | 7 lots10b5-1 |
| Feb 12, 2024 (view filing) | Feb 8-9 | 4 days | Hata Yujiro SPresident and CEO | SSale | −99.4K | $45.24 | −$4.50M | −12.8%677.9K after | 2 lots10b5-1 |
| Feb 5, 2024 (view filing) | Feb 1 | 4 days | Hata Yujiro SPresident and CEO | SSale | −628 | $45.00 | −$28.3K | −0.1%677.9K after | 2 lots10b5-1 |
| Jan 17, 2024 (view filing) | Jan 12-16 | 5 days | Hata Yujiro SPresident and CEO | SSale | −75.0K | $40.15 | −$3.01M | −10.0%677.9K after | 2 lots10b5-1 |
| Dec 19, 2023 (view filing) | Dec 15 | 4 days | Hata Yujiro SPresident and CEO | SSale | −75.0K | $35.03 | −$2.63M | −10.0%677.9K after | 10b5-1 |